Medtronic buys disease-management company for $200M

|About: Medtronic plc (MDT)|By:, SA News Editor

Medtronic (MDT) acquires closely held Cardiocom, a disease-management and patient-monitoring firm, for $200M.

Cardiocom's products, such as home glucose monitors for diabetics and weight scales, help limit the cost of treating patients with chronic diseases. The market for such equipment is set to be boosted by a new health rule that sanctions hospitals when their patients return within a month of being released. Customers include health insurers.